Guru Sonpavde describes the efficacy of chemotherapy with nivolumab in lymph node only 1st line UC patients. Tom describes the QOL data for EV pembro.

Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Medicine

Health & Fitness

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Share Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

Sign up to save your podcasts

Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

More shows like The Uromigos

TED Radio Hour

Freakonomics Radio

Planet Money

JAMA Clinical Reviews

Behind The Knife: The Surgery Podcast

Prostate Cancer Update

ASCO Daily News

The Diary Of A CEO with Steven Bartlett

OncLive® On Air

GU Cast | Urology Podcast

Oncology Today with Dr Neil Love

People I (Mostly) Admire

ZOE Science & Nutrition

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions